documents: EPA-HQ-OGC-2024-0391-0001
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPA-HQ-OGC-2024-0391-0001 | EPA | EPA-HQ-OGC-2024-0391 | Proposed Partial Settlement Agreement and Consent Decree, Claim Regarding Implementation of Endocrine Disruptor Screening Program Under the Section 408(p) of the Federal Food, Drug, and Cosmetic Act (FFDCA) | Notice | Consent Decree | 2024-10-11T04:00:00Z | 2024 | 10 | 2024-10-11T04:00:00Z | 2024-11-13T04:59:59Z | 2024-11-13T02:01:18Z | 2024-23633 | 0 | 0 | 09000064867c96f3 |
Links from other tables
- 1 row from regs_document_id in fr_regs_crossref